As of 2026-03-21, the Relative Valuation of Integra Lifesciences Holdings Corp (IART) is (164.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.94 USD, the upside of Integra Lifesciences Holdings Corp based on Relative Valuation is -1934.5%.
The range of the Relative Valuation is (161.82) - (203.30) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.4x - 38.7x | 28.1x |
| Forward P/E multiples | 20.8x - 30.7x | 21.4x |
| Fair Price | (161.82) - (203.30) | (164.01) |
| Upside | -1910.1% - -2374.1% | -1934.5% |
| Date | P/E |
| 2026-03-19 | -1.34 |
| 2026-03-18 | -1.34 |
| 2026-03-17 | -1.37 |
| 2026-03-16 | -1.36 |
| 2026-03-13 | -1.39 |
| 2026-03-12 | -1.38 |
| 2026-03-11 | -1.45 |
| 2026-03-10 | -1.44 |
| 2026-03-09 | -1.44 |
| 2026-03-06 | -1.47 |
| 2026-03-05 | -1.49 |
| 2026-03-04 | -1.57 |
| 2026-03-03 | -1.59 |
| 2026-03-02 | -1.57 |
| 2026-02-27 | -1.72 |
| 2026-02-26 | -1.71 |
| 2026-02-25 | -1.75 |
| 2026-02-24 | -1.74 |
| 2026-02-23 | -1.77 |
| 2026-02-20 | -1.84 |
| 2026-02-19 | -1.82 |
| 2026-02-18 | -1.81 |
| 2026-02-17 | -1.73 |
| 2026-02-13 | -1.71 |
| 2026-02-12 | -1.63 |
| 2026-02-11 | -1.69 |
| 2026-02-10 | -1.66 |
| 2026-02-09 | -1.65 |
| 2026-02-06 | -1.70 |
| 2026-02-05 | -1.64 |
| 2026-02-04 | -1.67 |
| 2026-02-03 | -1.63 |
| 2026-02-02 | -1.68 |
| 2026-01-30 | -1.68 |
| 2026-01-29 | -1.67 |
| 2026-01-28 | -1.64 |
| 2026-01-27 | -1.68 |
| 2026-01-26 | -1.74 |
| 2026-01-23 | -1.80 |
| 2026-01-22 | -1.84 |
| 2026-01-21 | -1.84 |
| 2026-01-20 | -1.81 |
| 2026-01-16 | -1.87 |
| 2026-01-15 | -1.91 |
| 2026-01-14 | -1.89 |
| 2026-01-13 | -1.86 |
| 2026-01-12 | -1.98 |
| 2026-01-09 | -2.05 |
| 2026-01-08 | -2.09 |
| 2026-01-07 | -1.98 |